🔗 Share this article

Chancellor Rachel Reeves has stated she is preparing "specific action to address cost of living issues" in the upcoming financial statement.

Speaking to the BBC, she emphasized that reducing price rises is a joint responsibility of both the administration and the central bank.

The UK's inflation rate is forecast to be the most elevated among the G7 industrialized countries this year and the following year.

Possible Energy Bill Measures

Reports indicate the government could take action to lower utility costs, for example by cutting the current 5% level of value-added tax charged on energy supplies.

Another approach is to lower some of the regulatory levies presently included in bills.

Budgetary Constraints and Analyst Expectations

The administration will receive the next assessment from the official forecaster, the Office for Budget Responsibility, on Monday, which will reveal how much space there is for these actions.

The view from the majority of analysts is that the Chancellor will have to introduce tax rises or spending cuts in order to fulfill her voluntary debt limits.

Previously on Thursday, calculations showed there was a £22 billion gap for the chancellor to address, which is at the more modest range of forecasts.

"It is a collective task between the Bank of England and the government to further reduce some of the drivers of price increases," the Chancellor informed the BBC in Washington, at the yearly gatherings of the IMF and global financial institution.

Tax Pledges and International Concerns

While much of the attention has been on probable tax increases, the chancellor said the latest figures from the OBR had not altered her vow to election pledges not to raise rates on earnings tax, sales tax or social security contributions.

She blamed an "unpredictable global environment" with rising geopolitical and trade issues for the fiscal revenue measures, probably to be directed on those "with the broadest shoulders."

Global Trade Disputes

Addressing apprehensions about the United Kingdom's economic relations with China she said: "Our national security always come first."

Recent declaration by China to tighten export controls on critical minerals and other resources that are essential for high-technology manufacturing led US President Donald Trump to suggest an extra 100% import tax on goods from China, raising the possibility of an all-out trade war between the two global powers.

The US Treasury Secretary called China's action "commercial pressure" and "a global supply chain power grab."

Questioned on considering the American proposal to participate in its conflict with the Asian nation, Reeves said she was "extremely troubled" by China's actions and encouraged the Chinese government "not to put up barriers and limit trade."

She said the move was "damaging for the world economy and generates further challenges."

"In my view there are sectors where we should confront Chinese policies, but there are also significant opportunities to export to China's economy, including financial services and other areas of the economy. We've got to maintain that equilibrium appropriate."

The chancellor also confirmed she was working with international partners "regarding our own critical minerals approach, so that we are reduced dependence."

Health Service Drug Pricing and Funding

Reeves also acknowledged that the cost the NHS spends on pharmaceuticals could rise as a result of ongoing discussions with the Trump administration and its pharmaceutical firms, in exchange for lower tariffs and investment.

Some of the biggest global pharmaceutical manufacturers have said in recent statements that they are either delaying or scrapping projects in the United Kingdom, with some attributing the low prices they are receiving.

Recently, the Science Minister said the cost the NHS pays for drugs would have to go up to stop businesses and drug research funding departing from the UK.

The Chancellor stated to media: "It has been observed as a result of the pricing regime, that medical research, innovative medicines have not been available in the United Kingdom in the way that they are in other European countries."

"We want to make sure that patients getting care from the NHS are able to obtain the top essential drugs in the globe. And so we are looking at all of that, and... seeking to attract more investment into Britain."